Castle Biosciences (CSTL) Other Gross PP&E Adjustments: 2018-2025
Historic Other Gross PP&E Adjustments for Castle Biosciences (CSTL) over the last 7 years, with Sep 2025 value amounting to $86.6 million.
- Castle Biosciences' Other Gross PP&E Adjustments rose 96.96% to $86.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $266.4 million, marking a year-over-year increase of 107.79%. This contributed to the annual value of $47.2 million for FY2024, which is 180.84% up from last year.
- Latest data reveals that Castle Biosciences reported Other Gross PP&E Adjustments of $86.6 million as of Q3 2025, which was up 16.88% from $74.1 million recorded in Q2 2025.
- Over the past 5 years, Castle Biosciences' Other Gross PP&E Adjustments peaked at $86.6 million during Q3 2025, and registered a low of $421,000 during Q1 2022.
- For the 3-year period, Castle Biosciences' Other Gross PP&E Adjustments averaged around $40.0 million, with its median value being $37.3 million (2024).
- Per our database at Business Quant, Castle Biosciences' Other Gross PP&E Adjustments slumped by 95.64% in 2022 and then soared by 2,840.14% in 2023.
- Castle Biosciences' Other Gross PP&E Adjustments (Quarterly) stood at $3.0 million in 2021, then soared by 85.70% to $5.5 million in 2022, then skyrocketed by 206.24% to $16.8 million in 2023, then soared by 180.84% to $47.2 million in 2024, then skyrocketed by 96.96% to $86.6 million in 2025.
- Its Other Gross PP&E Adjustments stands at $86.6 million for Q3 2025, versus $74.1 million for Q2 2025 and $58.5 million for Q1 2025.